Brooks John O, Vizueta Nathalie
Department of Psychiatry & Biobehavioral Sciences, UCLA Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA, USA.
Department of Psychiatry & Biobehavioral Sciences, UCLA Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA, USA.
J Psychiatr Res. 2014 Oct;57:12-25. doi: 10.1016/j.jpsychires.2014.05.018. Epub 2014 Jun 8.
Advances in functional neuroimaging have ushered in studies that have enhanced our understanding of the neuropathophysiology of bipolar disorder, but do not yet have clinical applications. We describe the major circuits (ventrolateral, dorsolateral, ventromedial, and anterior cingulate) thought to be involved in the corticolimbic dysregulation that may underlie mood states in patients with bipolar disorder. The potential clinical application of functional neuroimaging in bipolar disorder is considered in terms of prognostic, predictive, and treatment biomarkers. To date, most research has focused on prognostic biomarkers to differentiate patients with bipolar disorder from those with other affective or psychotic diagnoses, or healthy subjects. The search for treatment biomarkers, which suggest mechanisms of pharmacodynamic or treatment response, and predictive biomarkers has thus far involved only pediatric patients diagnosed with bipolar disorder. The results to date are encouraging and suggest that functional neuroimaging may be of eventual benefit in determining biomarkers of treatment response. Further refinement of biomarker identification, and perhaps even illness characterization are needed to find prognostic and predictive biomarkers of bipolar disorder.
功能神经影像学的进展开启了相关研究,增进了我们对双相情感障碍神经病理生理学的理解,但尚未应用于临床。我们描述了被认为与皮质边缘功能失调有关的主要神经回路(腹外侧、背外侧、腹内侧和前扣带回),这种失调可能是双相情感障碍患者情绪状态的基础。从预后、预测和治疗生物标志物的角度考虑了功能神经影像学在双相情感障碍中的潜在临床应用。迄今为止,大多数研究都集中在预后生物标志物上,以区分双相情感障碍患者与其他情感或精神病诊断患者或健康受试者。寻找提示药效动力学或治疗反应机制的治疗生物标志物以及预测生物标志物的研究,迄今为止仅涉及被诊断为双相情感障碍的儿科患者。迄今为止的结果令人鼓舞,表明功能神经影像学最终可能有助于确定治疗反应的生物标志物。需要进一步完善生物标志物的识别,甚至可能需要完善疾病特征描述,以找到双相情感障碍的预后和预测生物标志物。